Regenerative Medicine
Compounded GLP-1 Weight Loss
Cost-effective compounded semaglutide and tirzepatide programs through US-licensed 503A pharmacies, with full medical supervision.
Compounded GLP-1 medications offer access to the same active ingredients as Wegovy and Zepbound — semaglutide and tirzepatide — at substantially lower monthly cost. At Elements, we work only with US-licensed 503A and 503B compounding pharmacies that test for purity, sterility, and potency. Every program includes proper medical supervision: baseline labs, dose titration, ongoing follow-up, and lifestyle structure to preserve muscle.
The compounded GLP-1 landscape has shifted dramatically since 2022. During FDA-declared shortages of brand-name semaglutide and tirzepatide, compounding pharmacies legally produced these medications in bulk to meet patient demand. As shortages resolve, FDA restrictions on compounding tighten — but compounded versions remain available through 503A pharmacies for individual patient need and through 503B for ongoing supply where shortages persist. Elements stays current on the regulatory landscape and tells patients honestly which option is appropriate for their situation. We do not source from non-US pharmacies or research-only suppliers. Every patient gets baseline labs (CMP, lipid panel, A1c, TSH, lipase, pregnancy test), structured dose titration, follow-up at 4 and 12 weeks then quarterly, and protein/resistance training targets to ensure weight lost is preferentially fat rather than muscle. The standard side-effect profile (GI symptoms during titration, rare pancreatitis or gallbladder issues) and contraindications (MTC history, MEN2, severe gastroparesis, pancreatitis history, pregnancy) apply to compounded GLP-1s identically to brand-name.
Key Benefits
Common Questions
Frequently asked
Are compounded GLP-1s as effective as brand-name?
When sourced from a US-licensed 503A or 503B pharmacy that tests for purity, sterility, and potency, the active ingredient (semaglutide or tirzepatide) is identical to brand-name. The clinical effect is equivalent. The legitimacy concern is supply chain, not biology.
Is compounding still allowed?
The regulatory landscape shifts. During FDA-declared shortages of brand-name medications, compounding is broadly permitted. As shortages resolve, restrictions tighten. As of this page's update, some 503A pharmacies continue to compound under individual patient need rules. We stay current and tell patients honestly what's available.
What's the cost difference?
Brand-name (Wegovy, Zepbound) without insurance: $1,000–$1,500/month. Compounded versions: typically $400–$700/month including supervision and follow-up. With insurance coverage on brand-name (often with diabetes diagnosis), cost can drop to $25–$50 copay.
How do you ensure quality?
We work only with US-licensed 503A and 503B pharmacies that provide certificates of analysis for each batch — testing potency, sterility, and pyrogen content. We never use research-only or non-US suppliers.
Is the supervision the same?
Yes. Whether brand-name or compounded, every patient gets baseline labs, dose titration, follow-up at 4 and 12 weeks then quarterly, and protein/resistance training targets to preserve muscle.
Start here
Book now to talk through whether compounded glp-1 weight loss is the right fit for your goals, timeline, and recovery plan.
Book now →Related Protocols